The most common issues are gastrointestinal side effects
Achievement: Learning disabilities Adaptive behavior: Poor impulse control, poor personal boundaries, poor anger management, stubbornness, intrusive behavior, too friendly with strangers, poor daily living skills, developmental delays Attention: Attention-deficit/hyperactivity disorder (ADHD), poor attention or concentration, distractible Cognition: Intellectual disability, confusion under pressure, poor abstract skills, difficulty distinguishing between fantasy and reality, slower cognitive processing Executive functioning: Poor judgment, information-processing disorder, poor at perceiving patterns, poor cause and effect reasoning, inconsistent at linking words to actions, poor generalization ability Language: Expressive or receptive language disorders, grasp parts but not whole concepts, lack understanding of metaphor, idioms, or sarcasm Memory: Poor short-term memory, inconsistent memory and knowledge base Motor skills: Poor handwriting, poor fine motor skills, poor gross motor skills, delayed motor skill development (e.g., riding a bicycle at an appropriate age) Sensory processing and soft neurological problems: sensory processing disorder, sensory defensiveness, undersensitivity to stimulation Social communication: Intrude into conversations, inability to read nonverbal or social cues, "chatty" but without substance Secondary disabilities [edit] The secondary disabilities of FAS are those that arise later in life, secondary to central nervous system damage
Theres scant published research on GLP-1 microdosing, although some teams are studying it
(This analysis does not include all GLP-1s covered by Medicare, only those products with more recent FDA approvals that are also approved as weight loss medications.) Spending on Ozempic alone increased substantially between 2021 and 2022
